PMI Acquires U.S. IQOS Rights From Altria
The firms terminate their deal for the U.S. commercialization of the tobacco heating product. Read More
The firms terminate their deal for the U.S. commercialization of the tobacco heating product. Read More
The company expects full-year pro forma adjusted diluted EPS growth of 10-12 percent.Read More
The proposed takeover is still awaiting regulatory approval from the European Commission. Read More
Inequality limits the potential of technologies to improve public health, PMI poll shows. Read More
The offer is “even more attractive” in the changed economic climate, says CEO.Read More
The ITC should have consulted more the FDA prior to banning the device, say PMI lawyers. Read More
The industry’s move into pharma may be positive for public health. Read More
The company will expand its Tanauan facility to accommodate the product line. Read More
The investor joins Elliott and Bronte Capital in demanding a higher price. Read More
PMI executives are stressing the need for collaboration on ‘real’ solutions. Read More